Electrochemical cycloaddition produces triazabicyclo scaffolds with two stereocenters, suggesting broad application potential.
The established strategy unveils an electrochemical formal (3 + 2) cycloaddition/imidation sequence between N-aryl glycinamides and 5-methoxyoxazoles, furnishing diversely substituted imidazoline fused pyrrole-2,5-dione scaffolds. This diastereocontrolled cascade annulation operates with the assistance of ZnCl2 as a Lewis acid catalyst and provides two contiguous stereocenters as part of the [3.3.0]triazabicyclic core structure. An extensive range of distinct functionalities is well tolerated under this mild electrochemical condition, contributing to a broad substrate scope.
No takes yet. Share an insight, caveat, or question.
Mallick et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: